Granite Bio emerges from stealth with $100 million in funding, including a $30 million Series A led by Versant Ventures and Novartis Venture Fund and a $70 million Series B led by Forbion and Sanofi Ventures.
Amount Raised
$100 Million
Round Type
Series A
BaselBiotechnologyHealth CareTherapeuticsInvestors
Description
Granite Bio, a clinical-stage immunology company, announced it has emerged from stealth with $100 million in funding. This includes a $30 million Series A and a $70 million Series B. The company is working on innovative treatments for autoimmune diseases with its first-in-class antibodies. Granite is led by an experienced team with significant backgrounds in the pharmaceutical industry.
Quick answer
Granite Bio raised $100 Million in a Series A round, dated April 25, 2025. Investors: Sanofi Ventures, Versant Ventures, Novartis Venture Fund and Forbion. Granite Bio is based in Basel, Basel City, Switzerland.
- How much did Granite Bio raise?
- Granite Bio raised $100 Million in a Series A round on April 25, 2025.
- Who invested in Granite Bio?
- Sanofi Ventures, Versant Ventures, Novartis Venture Fund and Forbion are named as investors in this round.
- What does Granite Bio do?
- Granite Bio is a clinical-stage immunology company focused on developing innovative therapies for autoimmune diseases.
- Where is Granite Bio based and how big is it?
- Granite Bio is based in Basel, Basel City, Switzerland.
- Who are the decision-makers at Granite Bio?
- Fundz holds 1 contact at Granite Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Granite Bio that raised within 45 days of this round, from Fundz verified event records.
- Synaptogenix raised $5.5M on June 9, 2025.
- Gradalis raised $13M on June 5, 2025.
- Aeon raised $9.3M (Seed) on June 4, 2025.
- TuHURA Biosciences raised $13M (Private Equity) on June 3, 2025.
- Renasant Bio raised $30M on June 3, 2025.
- Vima Therapeutics raised $60M (Series A) on May 30, 2025.
Who to call at Granite Bio, and when
A new round usually means Granite Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Granite Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Granite Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Granite Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Granite Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGranite Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.